FPAS
PGEN icon

Focus Partners Advisor Solutions’s Precigen PGEN Stock Holding History

Focus Partners Advisor Solutions’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,186
Closed -$19.3K – 767
2024
Q2 		$19.3K Buy
+12,186
New +$17.7K ﹤0.01% 636

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Focus Partners Advisor Solutions's PGEN Position: Q3 2024 in Review

Focus Partners Advisor Solutions sold out of Precigen (PGEN) in Q3 2024, closing a stake of 12,186 shares — an estimated $19.3K sold.

Focus Partners Advisor Solutions first reported a position in PGEN in Q2 2024 and held it in 1 quarter. The position peaked at $19.3K in Q2 2024. 127 funds tracked by Wall St. Rank hold PGEN as of Q3 2024.

  • Focus Partners Advisor Solutions reported no remaining Precigen position as of Q3 2024 after selling out during the quarter.
  • Focus Partners Advisor Solutions sold 12,186 Precigen shares in Q3 2024, an estimated $19.3K.
  • Focus Partners Advisor Solutions first reported a position in Precigen in Q2 2024 and held it in 1 quarter.
  • Focus Partners Advisor Solutions's Precigen position peaked at $19.3K in Q2 2024.
  • 127 funds tracked by Wall St. Rank held Precigen as of Q3 2024.

Based on Focus Partners Advisor Solutions's 13F filing for Q3 2024, filed 14 Nov 2024.